ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

NGM NGM Biopharmaceuticals Inc

1.54
0.00 (0.00%)
最終更新日: 09:00:00
15分遅延
名称 銘柄コード 市場 種別
NGM Biopharmaceuticals Inc NGM NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 1.54 09:00:00
始値 安値 高値 終値 前日終値
1.54
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0522:19GLOBENGM Bio Announces Closing of Tender Offer
2024/3/2006:30GLOBENGM Bio to Present Two Posters Highlighting Clinical Data..
2024/3/1205:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/1205:13EDGAR2Form 8-K - Current report
2024/3/1205:05GLOBENGM Bio Provides Recent Business Highlights and Reports..
2024/3/0907:32EDGAR2Form SC 13E3 - Going private transaction by certain issuers
2024/3/0907:21EDGAR2Form SC 14D9 - Solicitation, recommendation statements
2024/2/2707:11EDGAR2Form SC14D9C - Written communication relating to third party..
2024/2/2707:01EDGAR2Form 8-K - Current report
2024/2/2623:03GLOBENGM Bio Has Entered into a Definitive Agreement and Plan of..
2024/2/2106:01GLOBENGM Bio to Participate in the Cowen 44th Annual Health Care..
2024/2/1508:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2220:09EDGAR2Form 8-K - Current report
2024/1/1908:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1908:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1908:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1806:47GLOBENGM Bio to Participate in the B. Riley Securities 4th Annual..
2024/1/0922:00GLOBENGM Bio Announces New Clinical Data from Ongoing Trial of..
2024/1/0221:30EDGAR2Form 8-K - Current report
2023/12/0507:19EDGAR2Form 8-K - Current report
2023/12/0506:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1323:45GLOBENGM Bio Presents Positive Phase 2b Results from the ALPINE 4..
2023/11/0908:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/0908:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0908:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0908:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0806:05GLOBENGM Bio to Participate in Upcoming Investor Conferences
2023/11/0305:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0305:06EDGAR2Form 8-K - Current report
2023/11/0305:01GLOBENGM Bio Reports Third Quarter 2023 Financial Results and..
2023/10/1806:28EDGAR2Form 8-K - Current report
2023/10/1205:05GLOBENGM Bio Announces Oral Plenary Presentation of Data from..
2023/9/2721:30PRNUSAlexandria Real Estate Equities, Inc.'s One-of-a-Kind,..
2023/9/1205:01EDGAR2Form 8-K/A - Current report: [Amend]
2023/8/1205:08EDGAR2Form 8-K - Current report
2023/8/0713:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/0506:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/0505:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
2023/8/0405:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0405:07EDGAR2Form 8-K - Current report
2023/8/0405:01GLOBENGM Bio Reports Second Quarter 2023 Financial Results and..
2023/5/2522:00GLOBENGM Bio to Participate in Upcoming Investor Conferences
2023/5/0905:05GLOBENGM Bio Announces Presentation of Data from Phase 2..
2023/5/0505:05GLOBENGM Bio Reports First Quarter 2023 Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock